1,425
Views
30
CrossRef citations to date
0
Altmetric
Original Articles

The impact of the codelivery of drug-siRNA by trimethyl chitosan nanoparticles on the efficacy of chemotherapy for metastatic breast cancer cell line (MDA-MB-231)

, , , , , & show all
Pages 889-896 | Received 17 Jan 2016, Accepted 25 Apr 2016, Published online: 17 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Ernestina Marianna De Francesco, Francesca Cirillo, Veronica Vella, Antonino Belfiore, Marcello Maggiolini & Rosamaria Lappano. (2022) Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress. Expert Opinion on Therapeutic Targets 26:6, pages 513-535.
Read now
Silvia Pegoraro, Gloria Ros, Michela Sgubin, Sara Petrosino, Alberto Zambelli, Riccardo Sgarra & Guidalberto Manfioletti. (2020) Targeting the intrinsically disordered architectural High Mobility Group A (HMGA) oncoproteins in breast cancer: learning from the past to design future strategies. Expert Opinion on Therapeutic Targets 24:10, pages 953-969.
Read now
Yinglong Sa, Lin Wang, Huiquan Shu & Jie Gu. (2018) Post-transcriptional suppression of TIMP-1 in epithelial-differentiated adipose-derived stem cells seeded bladder acellular matrix grafts reduces urethral scar formation. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 306-313.
Read now
Rui-Jun Ju, Lan Cheng, Xiao-Ming Peng, Teng Wang, Cui-Qing Li, Xiao-Li Song, Shuang Liu, Jian-Ping Chao & Xue-Tao Li. (2018) Octreotide-modified liposomes containing daunorubicin and dihydroartemisinin for treatment of invasive breast cancer. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 616-628.
Read now
Amir Mehdizadeh, Mohammad Hossein Somi, Masoud Darabi, Safar Farajnia, Abolfazl Akbarzadeh, Soheila Montazersaheb, Mehdi Yousefi & Mortaza Bonyadi. (2017) Liposome-mediated RNA interference delivery against Erk1 and Erk2 does not equally promote chemosensitivity in human hepatocellular carcinoma cell line HepG2. Artificial Cells, Nanomedicine, and Biotechnology 45:8, pages 1612-1619.
Read now

Articles from other publishers (25)

Ganeshlenin Kandasamy, Ravichandran Manisekaran & Manoj-Kumar Arthikala. (2024) Chitosan nanoplatforms in agriculture for multi-potential applications - Adsorption/removal, sustained release, sensing of pollutants & delivering their alternatives – A comprehensive review. Environmental Research 240, pages 117447.
Crossref
Humayra Afrin, Renu Geetha Bai, Raj Kumar, Sheikh Shafin Ahmad, Sandeep K. Agarwal & Md Nurunnabi. (2023) Oral delivery of RNAi for cancer therapy. Cancer and Metastasis Reviews 42:3, pages 699-724.
Crossref
Milad Ashrafizadeh, Kiavash Hushmandi, Sepideh Mirzaei, Saied Bokaie, Ashkan Bigham, Pooyan Makvandi, Navid Rabiee, Vijay Kumar Thakur, Alan Prem Kumar, Esmaeel Sharifi, Rajender S. Varma, Amir Reza Aref, Marcin Wojnilowicz, Ali Zarrabi, Hassan Karimi‐Maleh, Nicolas H. Voelcker, Ebrahim Mostafavi & Gorka Orive. (2022) Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy. Bioengineering & Translational Medicine 8:1.
Crossref
Anil Kumar Sahdev, Chaitany Jayprakash Raorane, Divya Shastri, Vinit Raj, Anita Singh & Seong Cheol Kim. (2022) Update on modified chitosan frameworks and their applications for food, wastewater, toxic heavy metals, dyes treatment and cancer drug delivery. Journal of Environmental Chemical Engineering 10:6, pages 108656.
Crossref
Sara Adibfar, Ali Masjedi, Atefeh Nazer, Bentolhoda Rashidi, Vahid Karpisheh, Sepideh Izadi, Hadi Hassannia, Jamshid Gholizadeh Navashenaq, Hamed Mohammadi, Mohammad Hojjat-Farsangi, Hanieh Tarokhian & Farhad Jadidi-Niaragh. (2022) Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses. Life Sciences 309, pages 121008.
Crossref
Asal Barshidi, Vahid Karpisheh, Fatemeh Karimian Noukabadi, Fariba Karoon Kiani, Mohammad Mohammadi, Negin Afsharimanesh, Farbod Ebrahimi, Seyed Hossein Kiaie, Jamshid Gholizadeh Navashenaq, Mohammad Hojjat-Farsangi, Naime Majidi Zolbanin, Ata Mahmoodpoor, Hadi Hassannia, Sanam Nami, Pooya Jalali, Reza Jafari & Farhad Jadidi-Niaragh. (2022) Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model. Pharmaceutical Research 39:8, pages 1851-1866.
Crossref
Andrew J. Hunt, Nontipa Supanchaiyamat, Kaewta Jetsrisuparb & Jesper T.N. KnijnenburgAnu Singh, Shefali Jaiswal, Santosh Kumar & Pradip K. Dutta. 2022. High‐Performance Materials from Bio‐based Feedstocks. High‐Performance Materials from Bio‐based Feedstocks 207 233 .
Goknur Kara, George A. Calin & Bulent Ozpolat. (2022) RNAi-based therapeutics and tumor targeted delivery in cancer. Advanced Drug Delivery Reviews 182, pages 114113.
Crossref
Vijay Sagar Madamsetty, Shima Tavakol, Saeid Moghassemi, Arezoo Dadashzadeh, John D. Schneible, Iman Fatemi, Abdolsamad Shirvani, Ali Zarrabi, Fereshteh Azedi, Ali Dehshahri, Abbas Aghaei Afshar, Kian Aghaabbasi, Abbas Pardakhty, Reza Mohammadinejad & Prashant Kesharwani. (2022) Chitosan: A versatile bio-platform for breast cancer theranostics. Journal of Controlled Release 341, pages 733-752.
Crossref
Krishan Kumar, Varsha Rani, Mohini Mishra & Ruchi Chawla. (2022) New paradigm in combination therapy of siRNA with chemotherapeutic drugs for effective cancer therapy. Current Research in Pharmacology and Drug Discovery 3, pages 100103.
Crossref
Saffiya Habib & Moganavelli Singh. 2022.
Milad Ashrafizadeh, Masoud Delfi, Farid Hashemi, Amirhossein Zabolian, Hossein Saleki, Morteza Bagherian, Negar Azami, Mahdi Vasheghani Farahani, Seyed Omid Sharifzadeh, Soodeh Hamzehlou, Kiavash Hushmandi, Pooyan Makvandi, Ali Zarrabi, Michael R. Hamblin & Rajender S. Varma. (2021) Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy. Carbohydrate Polymers 260, pages 117809.
Crossref
Farnaz Hajizadeh, Sadaf Moghadaszadeh Ardebili, Mahdi Baghi Moornani, Ali Masjedi, Fatemeh Atyabi, Melika Kiani, Afshin Namdar, Vahid Karpisheh, Sepideh Izadi, Behzad Baradaran, Gholamreza Azizi, Ghasem Ghalamfarsa, Gholamabas Sabz, Mehdi Yousefi & Farhad Jadidi-Niaragh. (2020) Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression. European Journal of Pharmacology 882, pages 173235.
Crossref
Hadi Hassannia, Mitra Ghasemi Chaleshtari, Fatemeh Atyabi, Mahshid Nosouhian, Ali Masjedi, Mohammad Hojjat‐Farsangi, Afshin Namdar, Gholamreza Azizi, Hamed Mohammadi, Ghasem Ghalamfarsa, Gholamabas Sabz, Sajad Hasanzadeh, Mehdi Yousefi & Farhad Jadidi‐Niaragh. (2019) Blockage of immune checkpoint molecules increases T‐cell priming potential of dendritic cell vaccine. Immunology 159:1, pages 75-87.
Crossref
Inés Serrano-Sevilla, Álvaro Artiga, Scott G. Mitchell, Laura De Matteis & Jesús M. de la Fuente. (2019) Natural Polysaccharides for siRNA Delivery: Nanocarriers Based on Chitosan, Hyaluronic Acid, and Their Derivatives. Molecules 24:14, pages 2570.
Crossref
Sanaz Naghizadeh, Behzad Mansoori, Ali Mohammadi, Hossein Samadi Kafil, Zohreh Mousavi, Ebrahim Sakhinia & Behzad Baradaran. (2018) Effects of HMGA2 gene downregulation by siRNA on lung carcinoma cell migration in A549 cell lines. Journal of Cellular Biochemistry 120:4, pages 5024-5032.
Crossref
Dan Li, Mengxuan Shi, Cheng Bao, Weier Bao, Liwei Zhang, Lulu Jiao, Tao Li & Yuan Li. (2019) Synergistically enhanced anticancer effect of codelivered curcumin and siPlk1 by stimuli-responsive α-lactalbumin nanospheres. Nanomedicine 14:5, pages 595-612.
Crossref
Narges Dastmalchi, Reza Safaralizadeh & Saeid Latifi-Navid. (2019) Nanoparticles as Therapeutic Delivery Systems in Relation to Cancer Diagnosis and Therapy. Current Nanoscience 15:3, pages 218-233.
Crossref
Hans Merzendorfer. 2019. Extracellular Sugar-Based Biopolymers Matrices. Extracellular Sugar-Based Biopolymers Matrices 95 151 .
Hans Merzendorfer & Ephraim Cohen. 2019. Extracellular Sugar-Based Biopolymers Matrices. Extracellular Sugar-Based Biopolymers Matrices 541 624 .
Vincenzo Giancotti, Natascha Bergamin, Palmina Cataldi & Claudio Rizzi. (2018) Epigenetic Contribution of High-Mobility Group A Proteins to Stem Cell Properties. International Journal of Cell Biology 2018, pages 1-20.
Crossref
Fatemeh Mottaghitalab, Ali Rastegari, Mehdi Farokhi, Rassoul Dinarvand, Hossein Hosseinkhani, Keng-Liang Ou, Daniel W. Pack, Chuanbin Mao, Meshkat Dinarvand, Yousef Fatahi & Fatemeh Atyabi. (2017) Prospects of siRNA applications in regenerative medicine. International Journal of Pharmaceutics 524:1-2, pages 312-329.
Crossref
Anish Babu & Rajagopal Ramesh. (2017) Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy. Marine Drugs 15:4, pages 96.
Crossref
Sanam Sadreddini, Reza Safaralizadeh, Behzad Baradaran, Leili Aghebati-Maleki, Mohammad Ali Hosseinpour-Feizi, Dariush Shanehbandi, Farhad Jadidi-Niaragh, Sevil Sadreddini, Hossein Samadi Kafil, Vahid Younesi & Mehdi Yousefi. (2017) Chitosan nanoparticles as a dual drug/siRNA delivery system for treatment of colorectal cancer. Immunology Letters 181, pages 79-86.
Crossref
Asal Barshidi, vahid karpisheh, Fatemeh Karimian Noukabadi, Fariba Karoon Kiani, Negin Afsharimanesh, Farbod Ebrahimi, Seyed Hossein Kiaie, Pooya Jalali, Mohammad Hojjat-Farsangi, Naime Majidi Zolbanin, Ata Mahmoodpoor, hadi Hassannia, Sanam Nami, Reza Jafari & Farhad Jadidi-Niaragh. (2021) Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.